FDA reverses course on Regenxbio’s childhood gene therapy after rejection

FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program

The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea

Genetically Engineered Babies Are Banned. Tech Titans Are Trying to Make One

Why controversial scientific ideas like the keto diet for anorexia deserve careful consideration, not automatic dismissal

This article explores the tension between scientific consensus and controversial ideas, using the proposal that a ketogenic diet could treat

FDA Clears NIH-Supported Gene Therapy MMA-101 for First Human Trial in Rare Metabolic Disorder

The FDA has cleared an Investigational New Drug (IND) application for MMA-101, an AAV-based gene therapy candidate developed with NIH suppor

Blueberry bioactives show promise for children's cognition and mood, but stronger clinical evidence needed

A narrative review published in Nutrients examines the potential cognitive and mood benefits of blueberry bioactives (anthocyanins, flavonoi

Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma

Life Biosciences, a Boston-based biotech startup, has conducted the world's first gene therapy on a living patient aimed at reversing cellul